Jefferies Initiates Coverage On Methode Electronics with Buy Rating, Announces Price Target of $52
Jefferies analyst David Kelley initiates coverage on Methode Electronics (NYSE:MEI) with a Buy rating and announces Price Target of $52.
Mobileye Has Upside Backed By Automotive ADAS Leadership As Supply Chain Recovery Kicks In, Analysts Say
Mizuho analyst Vijay Rakesh initiated coverage on Mobileye Global Inc (NASDAQ: MBLY) with a
Analyst Says IO Biotech’s Cancer Treatment Approach ‘Differentiated’
HC Wainwright has initiated coverage on Denmark-based cancer firm IO Biotech Inc (NASDAQ:IOBT) with a Buy rating and a price target of $10.…
Evercore ISI Group Initiates Coverage On Mobileye Global with Outperform Rating, Announces Price Target of $36
Evercore ISI Group analyst Chris McNally initiates coverage on Mobileye Global (NASDAQ:MBLY) with a Outperform rating and announces Price Target of $36.
MongoDB Analysts See Upside Over Long-Term, Thanks To Fast-Growing Database Market
Morgan Stanley analyst Sanjit Singh downgraded MongoDB, Inc (NASDAQ:MDB) from Overweight to Equal-Weight and cut the price target from $368 to $215.…
Why This Mobileye Analyst Prefers To Stay On The Sidelines, Even As The Rest Are Bullish
Mobileye Global Inc’s (NASDAQ: MBLY) shares traded higher in the premarket on Monday after several analysts began coverage on the stock with positive ratings.
UBS Initiates Coverage On Discover Financial with Neutral Rating, Announces Price Target of $120
UBS analyst Erika Najarian initiates coverage on Discover Financial (NYSE:DFS) with a Neutral rating and announces Price Target of $120.
UBS Initiates Coverage On American Express with Neutral Rating, Announces Price Target of $168
UBS analyst Erika Najarian initiates coverage on American Express (NYSE:AXP) with a Neutral rating and announces Price Target of $168.
Morgan Stanley Initiates Coverage On Sportradar Gr with Equal-Weight Rating, Announces Price Target of $12
Morgan Stanley analyst Stephen Grambling initiates coverage on Sportradar Gr (NASDAQ:SRAD) with a Equal-Weight rating and announces Price Target of $12.
Lake Street Assumes Streamline Health Solns at Buy, Announces Price Target of $3
Lake Street analyst Brooks O'Neil assumes Streamline Health Solns (NASDAQ:STRM) with a Buy rating and announces Price Target of $3.